Since its FDA approval for cosmetic purposes in 2002, Botox has been used for the purpose of wrinkle reduction. Up until the FDA approval of Dysport in May of 2009, there was no other botulinum toxin treatment on the market other than Botox. While Dysport has had a slow introduction into the market, a new study may give it the extra boost it needs.
According to the study, which was presented at the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) 2010 Annual Fall Meeting, Dysport is significantly more effective than Botox Cosmetic for the treatment of crow’s feet.
Ninety subjects were assessed on day zero and day 30 following treatment by both Botox and Dysport. The double-blind study found that Dysport was hands-down more effective than the well-established Botox Cosmetic.
“Botox has long been considered the gold standard of injectables, so this data showing Dysport’s stronger efficacy is compelling,” Corey D. Maas, MD, AAFPRS Group Vice President for Public and Regulatory Affairs, told Plastic Surgery Practice.
Based on the findings, patients who are interested in treating their crow’s feet may want to reconsider what product they ask for. The study also found that Dysport is more effective in treating hyperfunctional frown lines. For more information on Dysport in Bakersfield, please contact The California Institute of Cosmetic & Reconstructive Surgery for a consultation.
To Your Health & Beauty,